Market Outlook
The India Radiotherapy Devices Market was valued at USD 144.20 million in 2024 and is projected to reach USD 241.45 million by 2030, growing at a CAGR of 8.93% during the forecast period. The market is being driven by a growing burden of cancer cases across the country, a shift toward advanced oncology treatment modalities, and expanding healthcare infrastructure, particularly in urban and tier-2 cities. Increasing awareness regarding the benefits of radiotherapy and improved diagnosis rates are also fueling the adoption of radiotherapy devices in the country.
Moreover, favorable government initiatives and increased investments in public and private sector healthcare facilities are catalyzing the demand for technologically advanced radiotherapy systems. Collaborations between Indian medical institutions and global radiotherapy manufacturers are enabling the availability of cutting-edge solutions for cancer treatment. As India continues to battle a rising cancer incidence rate, radiotherapy devices are emerging as critical components in comprehensive oncology care, making the market one of the most promising sectors in the Indian medical devices industry.
Browse market data Figures spread through 180 Pages and an in-depth TOC on “India Radiotherapy Devices Market” – https://www.techsciresearch.com/report/india-radiotherapy-devices-market/27692.html
Market Driver Analysis
One of the primary drivers propelling the India radiotherapy devices market is the escalating prevalence of cancer. According to the Indian Council of Medical Research (ICMR), India reported over 1.5 million new cancer cases in 2022, and this number is expected to rise significantly due to aging demographics, lifestyle factors, and environmental influences. Breast cancer, lung cancer, and cervical cancer are among the most common types, which often require radiotherapy as part of their treatment protocol. The rise in such cases has increased the demand for radiotherapy services across the country.
Additionally, the expansion of the country’s healthcare infrastructure, particularly with the government’s focus on schemes such as Ayushman Bharat and the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), is fostering growth in the availability and accessibility of advanced cancer treatments. Over 1,500 new hospitals and specialty care centers have been added in the last five years, and many are equipped with dedicated oncology departments, further boosting the radiotherapy device demand.
Technological innovation is also a key growth driver. India is witnessing the introduction of advanced systems such as image-guided radiotherapy (IGRT), stereotactic body radiation therapy (SBRT), and intensity-modulated radiation therapy (IMRT), offering improved precision and better patient outcomes. For instance, Elekta and Varian have launched next-generation systems in India that reduce treatment time and improve accuracy. These improvements are encouraging oncologists and hospital administrators to replace legacy systems with more advanced equipment.
Another supporting factor is the rising number of trained oncologists and radiotherapy technologists. Medical institutions across India are expanding postgraduate seats and offering fellowships in radiation oncology, addressing the earlier challenge of limited human resource capacity. The simultaneous growth in insurance penetration—life and health insurance together reached over 56% penetration in 2023—is also increasing patient affordability for costly radiotherapy treatments.
Market Trends Analysis
A significant trend shaping the India radiotherapy devices market is the transition toward precision and personalized oncology treatments. The integration of AI-driven planning software with radiotherapy systems is allowing oncologists to tailor therapies according to individual patient tumor biology and treatment response, which results in higher efficacy and fewer side effects. Companies like Siemens and Philips are developing AI-enabled diagnostic and therapeutic modules that improve workflow and accuracy in radiotherapy.
Another trend is the growing adoption of telemedicine and remote planning in radiotherapy. Especially after the COVID-19 pandemic, there has been a push toward decentralizing oncology services. Cancer care centers in tier-2 and tier-3 cities are connecting with specialists in metro cities via telemedicine platforms to receive remote radiation treatment planning and consultation. This trend is expanding the reach of radiotherapy beyond major urban centers and is expected to improve equity in cancer care delivery.
Furthermore, there is a rising demand for compact, mobile radiotherapy units to cater to underserved rural areas. These devices are designed to be portable and operational in resource-limited settings, offering a pragmatic solution for geographically dispersed populations. Companies are also exploring battery-powered or hybrid-energy models to address power supply challenges in rural India.
Investment in local manufacturing under India’s “Make in India” initiative is another major trend. Companies like Healthcare Global Enterprises and Tata Memorial Centre are partnering with global players to manufacture parts and systems locally, thereby reducing costs and improving supply chain resilience. Moreover, green radiotherapy technologies aimed at reducing radiation waste and power consumption are gaining traction among sustainability-focused institutions.
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=27692
Market Challenges Analysis
Despite the promising outlook, the India radiotherapy devices market faces several challenges. A key hurdle is the high capital investment required for installing and maintaining radiotherapy systems. A linear accelerator (LINAC), for example, costs upwards of INR 20 crore (USD 2.4 million), including infrastructure and maintenance. This limits the penetration of advanced systems to only high-budget hospitals and specialized cancer centers, leaving a significant treatment gap in rural and semi-urban areas.
Another major issue is the uneven distribution of radiotherapy facilities. According to the Atomic Energy Regulatory Board (AERB), there are only about 550 operational radiotherapy machines in India, while WHO recommends one machine per million population. This indicates a significant shortfall, especially when considering India’s population of over 1.4 billion. Patients in smaller towns and villages often have to travel hundreds of kilometers for each session, leading to dropout from treatment cycles.
Additionally, the lack of trained personnel such as medical physicists, radiation therapists, and radiation oncologists poses a bottleneck to effective service delivery. A study from the Association of Radiation Oncologists of India revealed that there is a 40% shortage of trained radiation oncology staff in the country. Coupled with limited continuing education and upskilling opportunities, this results in suboptimal utilization of existing radiotherapy systems.
Also, frequent regulatory delays and complicated licensing processes for radiation equipment discourage smaller players and startups from entering the market. Import duties and taxes on high-end machines further raise procurement costs. All these factors collectively slow down market expansion and innovation, despite the increasing demand for cancer treatment services.
Segmentation
India Radiotherapy Devices Market, By Type:
- External Beam Radiation Therapy Device
- Internal Beam Radiation Therapy Device
- Others
India Radiotherapy Devices Market, By Application:
- Breast Cancer
- Cervical Cancer
- Colon and Rectum Cancers
- Stomach Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Liver Cancer
- Other
India Radiotherapy Devices Market, By End User:
- Hospitals & Clinics
- Cancer Care Centers
- Others
Regional Analysis
The regional distribution of radiotherapy devices in India reveals significant disparities, primarily influenced by infrastructure, economic development, and healthcare access. The South Indian region, particularly states like Tamil Nadu, Karnataka, and Kerala, leads in the deployment of radiotherapy devices. These states benefit from advanced healthcare systems, a high density of private multispecialty hospitals, and proactive government health policies. Karnataka, for instance, hosts one of the highest numbers of radiotherapy installations in the country due to institutions like Kidwai Memorial Institute of Oncology and HCG Cancer Centre.
Western India, especially Maharashtra and Gujarat, also commands a significant market share due to well-established cancer treatment facilities like Tata Memorial Hospital and Gujarat Cancer & Research Institute. Maharashtra alone accounts for over 15% of radiotherapy procedures conducted annually in India. Mumbai and Pune have emerged as key medical hubs, attracting patients from neighboring states and abroad.
The North Indian region, with states like Delhi, Uttar Pradesh, and Punjab, is rapidly expanding its radiotherapy capacity. Delhi NCR features premier oncology centers like AIIMS and Rajiv Gandhi Cancer Institute, driving demand for advanced radiotherapy equipment. Meanwhile, Uttar Pradesh, with its growing population and healthcare infrastructure investment, is emerging as a priority region for radiotherapy device deployment, particularly in public-private partnership models.
In Eastern India, West Bengal dominates the regional landscape with institutions like Chittaranjan National Cancer Institute. However, infrastructure in states like Bihar and Odisha still lags behind, limiting the market potential in those areas. These regions require substantial investment to catch up with the national average in terms of radiotherapy machine-to-population ratios.
The Northeastern states present the lowest penetration of radiotherapy devices, attributed to geographic inaccessibility, lower healthcare spending, and limited availability of specialists. However, government initiatives and World Bank-funded healthcare projects are gradually enabling installations in states like Assam and Meghalaya.
Urban-rural disparities remain a critical issue. While Tier-1 cities have access to cutting-edge technologies like proton therapy and IGRT, rural India faces acute shortages. Nearly 70% of India’s population resides in rural areas, yet only around 30% of radiotherapy centers are located there. This geographic skew continues to impact equitable access to radiotherapy services.
Primary Catalysts and Hindrances
The primary growth catalysts for the India Radiotherapy Devices Market include rising cancer incidence, technological advancements, increased healthcare investments, and policy-level support. Growing collaborations between public and private institutions and an expanding base of trained professionals also play a vital role. However, hindrances such as high capital costs, infrastructure gaps, regulatory bottlenecks, and workforce shortages are slowing down the market’s full potential. The need for balanced geographic expansion and affordability solutions remains critical.
Key Players and Analysis
- Siemens Healthcare Diagnostics Ltd.
- Elekta Medical Systems India Pvt. Ltd
- Koninklijke Philips N.V.
- Accuray Medical Equipment India Pvt. Ltd.
- Hitachi High-Tech India Pvt. Ltd.
- Varian Medical Systems
- Healthcare Global Enterprises Ltd.
Future Outlook
- Expansion of radiotherapy centers in Tier-2 and Tier-3 cities.
- Increasing local manufacturing under “Make in India.”
- Wider adoption of AI-driven treatment planning tools.
- Launch of mobile radiotherapy units for rural regions.
- Strengthening tele-radiotherapy consultation networks.
- Surge in insurance coverage and reimbursement support.
- Greater public-private partnerships in cancer care.
- Upskilling programs for radiation technologists and oncologists.
- Integration of radiotherapy data with national health records.
- Rollout of energy-efficient and green radiotherapy systems.
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=27692
Recent Reports –
Gastrointestinal Stents Market – https://www.techsciresearch.com/report/gastrointestinal-stents-market/20621.html
Laboratory Proficiency Testing Market – https://www.techsciresearch.com/report/laboratory-proficiency-testing-market/20624.html
Vaginal Rejuvenation Market – https://www.techsciresearch.com/report/vaginal-rejuvenation-market/21712.html
In-Vitro Fertilization Market – https://www.techsciresearch.com/report/in-vitro-fertilization-market/15131.html
Neomycin Sulphate Market – https://www.techsciresearch.com/report/neomycin-sulphate-market/28764.html
Contact
US –
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
